产品介绍：
产品说明
一般描述
VPC51299 is a potent low micromolar inhibitor containing a vinyl phosphonate head group and possessing a half-life of approximately 90 min in rats when dosed intravenously. Previously developed LPA1/LPA3 receptor antagonists contain a labile phosphate head group which impairs evaluation of scaffold LPA receptor antagonists in vivo. VPC51299 has replaced the phosphate with a more stable head group while retaining potency at both LPA1 and LPA3 to facilitate future in vivo studies of the biological functions of these receptors. This product is covered by Patent Number US 8,283,339 B2. Avanti manufactures this under license from University of Virginia.
包装
5 mL Amber Glass Screw Cap Vial (857347P-1mg)
基本信息
| 经验(实验)分子式 | C34H50 F3N2O6P |
| 分子量 | 670.74 |
| NACRES | NA.25 |
产品性质
| 测定 | >99% (TLC) |
| 形式 | powder |
| 包装 | pkg of 1 × 1 mg (857347P-1mg) |
| manufacturer/tradename | Avanti Polar Lipids 857347P |
| 运输 | dry ice |
| 储存温度 | −20℃ |
| SMILES string | CCCCCCCCCCCCCCCC(N[C@H](CC1=CC=C(OCC2=NC=CC(OCC(F)(F)F)=C2)C=C1)/C=C/P(O)(O)=O)=O |
安全信息
| 储存分类代码 | 13 - Non Combustible Solids |
| WGK | WGK 3 |
